Uli Christian BROEDL,Odd-Erik JOHANSEN,Gabriel Woojai KIM,Eric Williams MAYOUX,Afshin SALSALI,Nima SOLEYMANLOU,Maximilian von EYNATTEN,Hans-Juergen WOERLE,David Z.I. CHERNEY,Bruce A. PERKINS,Andreas D
申请号：
US14855576
公开号：
US20160000816A1
申请日:
2015.09.16
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The present invention relates to certain SGLT-2 inhibitors for treating and/or preventing oxidative stress, for example in patients with type 1 or type 2 diabetes, as well as to the use of such SGLT-2 inhibitors in treatment and/or prevention of cardiovascular diseases in patients, for example type 1 or type 2 diabetes patients. The present invention further relates to certain SGLT-2 inhibitors for treating and/or preventing a metabolic disorder and preventing, reducing the risk of or delaying the occurrence of a cardiovascular event in patients, for example patients with type 1 or type 2 diabetes.
